Prognostic Epigenetics

A. Sharma, E. Abdelfatah, M. Al Eissa, N. Ahuja

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

Abstract

Disease manifestation results from the interaction of the genome with environment stimuli in a complex interplay that ultimately affects both the structure and function of the genome. Both genetic and epigenetic changes affect the genome and are equally important players in this process and ultimately affect the disease outcomes. The past decades have seen an exponential increase in our understanding of both genetic and epigenetic events in the normal and disease states with the advent of whole genome technologies. As the cost of these whole genome technologies has diminished, there is now emerging use of biomarkers including single gene as well as multigene sets or whole arrays to accurately predict the course or the outcome of a particular disease. This review summarizes the current knowledge on both genetic and epigenetic changes in genes associated with various diseases with a special focus on cancer. Epigenetic changes should be considered in conjunction with genetic changes to be exploited in the clinics as biomarkers for prognosis.

Original languageEnglish
Title of host publicationMedical Epigenetics
PublisherElsevier Inc.
Pages177-195
Number of pages19
ISBN (Electronic)9780128032404
ISBN (Print)9780128032398
DOIs
Publication statusPublished - 1 Jul 2016

Fingerprint

Epigenomics
Genes
Genome
Biomarkers
Technology
Costs and Cost Analysis
Neoplasms

Keywords

  • Biomarker
  • CIMP
  • Epigenetics
  • Histones
  • MSI
  • Noncoding RNA

Cite this

Sharma, A., Abdelfatah, E., Al Eissa, M., & Ahuja, N. (2016). Prognostic Epigenetics. In Medical Epigenetics (pp. 177-195). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-803239-8.00011-9
Sharma, A. ; Abdelfatah, E. ; Al Eissa, M. ; Ahuja, N. / Prognostic Epigenetics. Medical Epigenetics. Elsevier Inc., 2016. pp. 177-195
@inbook{5ace355ab132436385ca8210e3235c50,
title = "Prognostic Epigenetics",
abstract = "Disease manifestation results from the interaction of the genome with environment stimuli in a complex interplay that ultimately affects both the structure and function of the genome. Both genetic and epigenetic changes affect the genome and are equally important players in this process and ultimately affect the disease outcomes. The past decades have seen an exponential increase in our understanding of both genetic and epigenetic events in the normal and disease states with the advent of whole genome technologies. As the cost of these whole genome technologies has diminished, there is now emerging use of biomarkers including single gene as well as multigene sets or whole arrays to accurately predict the course or the outcome of a particular disease. This review summarizes the current knowledge on both genetic and epigenetic changes in genes associated with various diseases with a special focus on cancer. Epigenetic changes should be considered in conjunction with genetic changes to be exploited in the clinics as biomarkers for prognosis.",
keywords = "Biomarker, CIMP, Epigenetics, Histones, MSI, Noncoding RNA",
author = "A. Sharma and E. Abdelfatah and {Al Eissa}, M. and N. Ahuja",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/B978-0-12-803239-8.00011-9",
language = "English",
isbn = "9780128032398",
pages = "177--195",
booktitle = "Medical Epigenetics",
publisher = "Elsevier Inc.",
address = "United States",

}

Sharma, A, Abdelfatah, E, Al Eissa, M & Ahuja, N 2016, Prognostic Epigenetics. in Medical Epigenetics. Elsevier Inc., pp. 177-195. https://doi.org/10.1016/B978-0-12-803239-8.00011-9

Prognostic Epigenetics. / Sharma, A.; Abdelfatah, E.; Al Eissa, M.; Ahuja, N.

Medical Epigenetics. Elsevier Inc., 2016. p. 177-195.

Research output: Chapter in Book/Report/Conference proceedingChapterResearchpeer-review

TY - CHAP

T1 - Prognostic Epigenetics

AU - Sharma, A.

AU - Abdelfatah, E.

AU - Al Eissa, M.

AU - Ahuja, N.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Disease manifestation results from the interaction of the genome with environment stimuli in a complex interplay that ultimately affects both the structure and function of the genome. Both genetic and epigenetic changes affect the genome and are equally important players in this process and ultimately affect the disease outcomes. The past decades have seen an exponential increase in our understanding of both genetic and epigenetic events in the normal and disease states with the advent of whole genome technologies. As the cost of these whole genome technologies has diminished, there is now emerging use of biomarkers including single gene as well as multigene sets or whole arrays to accurately predict the course or the outcome of a particular disease. This review summarizes the current knowledge on both genetic and epigenetic changes in genes associated with various diseases with a special focus on cancer. Epigenetic changes should be considered in conjunction with genetic changes to be exploited in the clinics as biomarkers for prognosis.

AB - Disease manifestation results from the interaction of the genome with environment stimuli in a complex interplay that ultimately affects both the structure and function of the genome. Both genetic and epigenetic changes affect the genome and are equally important players in this process and ultimately affect the disease outcomes. The past decades have seen an exponential increase in our understanding of both genetic and epigenetic events in the normal and disease states with the advent of whole genome technologies. As the cost of these whole genome technologies has diminished, there is now emerging use of biomarkers including single gene as well as multigene sets or whole arrays to accurately predict the course or the outcome of a particular disease. This review summarizes the current knowledge on both genetic and epigenetic changes in genes associated with various diseases with a special focus on cancer. Epigenetic changes should be considered in conjunction with genetic changes to be exploited in the clinics as biomarkers for prognosis.

KW - Biomarker

KW - CIMP

KW - Epigenetics

KW - Histones

KW - MSI

KW - Noncoding RNA

UR - http://www.scopus.com/inward/record.url?scp=84988246865&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-803239-8.00011-9

DO - 10.1016/B978-0-12-803239-8.00011-9

M3 - Chapter

SN - 9780128032398

SP - 177

EP - 195

BT - Medical Epigenetics

PB - Elsevier Inc.

ER -

Sharma A, Abdelfatah E, Al Eissa M, Ahuja N. Prognostic Epigenetics. In Medical Epigenetics. Elsevier Inc. 2016. p. 177-195 https://doi.org/10.1016/B978-0-12-803239-8.00011-9